by adminAdrianRamirez | Feb 21, 2017 | HempMeds Brasil, Press Releases
SAN DIEGO, Feb. 21, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the...
by adminAdrianRamirez | Feb 15, 2017 | HempMeds Brasil, Press Releases, Scientific Research
Article details the groundbreaking decision and possible implications for Alzheimer’s patients SAN DIEGO, Feb. 15, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded Cannabis Company in the United States, subsidiary HempMeds®...
by adminAdrianRamirez | Feb 14, 2017 | Kannaway, Press Releases
SAN DIEGO, Feb. 14, 2017 — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary, Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding an exclusive Red-Carpet Event in Phoenix, Az., this...
by adminAdrianRamirez | Feb 13, 2017 | HempMeds, Press Releases
Customers Now Have Ability to Earn Commissions Based on New Customer Referrals SAN DIEGO, Feb. 13, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® is...
by adminAdrianRamirez | Feb 9, 2017 | Press Releases
SAN DIEGO, Feb. 8, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that at The Money Show Orlando, Medical Marijuana, Inc., Chief Executive Officer, Dr. Stuart Titus, will speak to...
by adminAdrianRamirez | Feb 7, 2017 | HempMeds Brasil, Press Releases
National Health Surveillance Agency ANVISA Authorizes Doctor’s Prescription for RSHO™ to Treat Patient Suffering from Effects of Alzheimer’s Disease SAN DIEGO, Feb. 7, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly...